logo

DYN

Dyne
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

DYN Profile

Dyne Therapeutics, Inc.

A biotechnology company developing innovative muscle biology-based therapies for serious muscle diseases and injuries

Biological Technology
12/01/2017
09/17/2020
NASDAQ Stock Exchange
191
12-31
Common stock
1560 Trapelo Road, Waltham, Massachusetts 02451
--
Dyne Therapeutics, Inc., was incorporated under the laws of the State of Delaware on December 1, 2017. The company is building a leading muscle disease company dedicated to developing innovative life-changing therapies for patients with genetically driven diseases. The company is leveraging its proprietary FORCE platform to overcome the limitations of current muscle tissue delivery and develop modern oligonucleotide therapies for muscle diseases.